Back to Search
ANGELA EAKIN, MD
MD
Family Medicine Physician
NPI: 1871857995Individual
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
ML60296568(WA)
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
MD042953(DC)
Research & Publications (18)
Delayed administration of a matrix metalloproteinase inhibitor limits progressive brain injury after hypoxia-ischemia in the neonatal rat.
PMID 18694515·J Neuroinflammation·2008
7-preclinical
A randomized controlled trial of a close monitoring program for minor depression and distress.
PMID 18498013·J Gen Intern Med·2008
2-rct
Discordant localization of WFA reactivity and brevican/ADAMTS-derived fragment in rodent brain.
PMID 18221525·BMC Neurosci·2008
4-observational
Versican and brevican are expressed with distinct pathology in neonatal hypoxic-ischemic injury.
PMID 17972319·J Neurosci Res·2008
7-preclinical
The effect of hypoxic-ischemic brain injury in perinatal rats on the abundance and proteolysis of brevican and NG2.
PMID 15817274·Exp Neurol·2005
4-observational
Steady-state kinetics of the hypoxanthine phosphoribosyltransferase from Trypanosoma cruzi.
PMID 15210120·Biochim Biophys Acta·2004
7-preclinical
Saturation mutagenesis, complement selection, and steady-state kinetic studies illuminate the roles of invariant residues in active site loop I of the hypoxanthine phosphoribosyltransferase from Trypanosoma cruzi.
PMID 15158715·Biochim Biophys Acta·2004
4-observational
Interactions at the dimer interface influence the relative efficiencies for purine nucleotide synthesis and pyrophosphorolysis in a phosphoribosyltransferase.
PMID 14698288·J Mol Biol·2004
7-preclinical
Functional roles for amino acids in active site loop II of a hypoxanthine phosphoribosyltransferase.
PMID 12922174·Biochim Biophys Acta·2003
7-preclinical
Mechanism of action of the antitumor agents 6-benzoyl-3,3-disubstituted-1,5-diazabicyclo[3.1.0]hexane-2,4-diones: potent inhibitors of human type II inosine 5'-monophosphate dehydrogenase.
PMID 11668509·Int J Cancer·2001
8-other
Investigation of the functional role of active site loop II in a hypoxanthine phosphoribosyltransferase.
PMID 11476964·Biochim Biophys Acta·2001
7-preclinical
Induction of Tmolt4 leukemia cell death by 3,3-disubstituted-6,6-pentamethylene-1,5-diazabicyclo[3.1.0]hexane-2-4-diones: specificity for type II inosine 5'-monophasphate dehydrogenase.
PMID 11454943·J Pharmacol Exp Ther·2001
8-other
Implications of selective type II IMP dehydrogenase (IMPDH) inhibition by the 6-ethoxycarbonyl-3,3-disubstituted-1,5-diazabicyclo[3.1.0]hexane-2,4-diones on tumor cell death.
PMID 11377400·Biochem Pharmacol·2001
8-other
The role for an invariant aspartic acid in hypoxanthine phosphoribosyltransferases is examined using saturation mutagenesis, functional analysis, and X-ray crystallography.
PMID 11258886·Biochemistry·2001
7-preclinical
Efficient identification of inhibitors targeting the closed active site conformation of the HPRT from Trypanosoma cruzi.
PMID 11137818·Chem Biol·2000
7-preclinical
Selective inhibition of human Molt-4 leukemia type II inosine 5'-monophosphate dehydrogenase by the 1,5-diazabicyclo[3.1.0]hexane-2,4-diones.
PMID 11076502·Biochemistry·2000
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 6002 N LIDGERWOOD ST
SPOKANE, WA 99208 - Phone
- (509) 482-4402
Quick Facts
- NPI
- 1871857995
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 18
Are you this provider?
Claim Your Profile